An important limitation of the abovementioned studies that may have limited understanding the actual Gal-3's predictive value is that Gal-3 measurements were only done once at baseline and the investigators were not able to explore the value of changing Gal-3 levels and how they might impact future stroke risk. The gene discussed is LGALS3; the disease is stroke disorder.